to BioTechniques free email alert service to receive content updates.

Phenotypic High Content Screening and Label-free Approaches to Accelerate Drug Discovery Webinar

Available Now On Demand:

Cell-based multivariate phenotypic assays can accelerate both target-centric and phenotypic drug discovery as their rich content provides information on desired effects and possible modes of action. Growing evidence indicates that results generated from phenotypic assays are especially effective in discovering first-in-class drugs. This is why many scientists are using phenotypic approaches alongside traditional target-based methods to make new findings and to ensure the physiological relevance of their results early in the process.

This webinar features:

* Presentations on two different approaches to phenotypic screening, from running the screen to identifying hits.

* A discussion on the use of high content imaging in phenotypic screening for drug discovery research.

* The latest research on the application of cell-based label-free phenotypic assays for analyzing G-protein-coupled receptor (GPCR) responses.

* A live Q&A session


Patrick C.H. Lo, Ph.D.
Senior Editor, BioTechniques


David L. Roman, Ph.D.
Associate Professor of Medicinal and Natural Products Chemistry, Department of Pharmaceutical Sciences & Experimental Therapeutics, The University of Iowa College of Pharmacy

Val J. Watts, Ph.D.
Professor of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University

Christopher Hale, Ph.D.
Scientist, Discovery Technologies, Amgen Inc.

Sponsored by:


Available Now On Demand:

27 April 2011
Principles and Applications of 
Live Cell Imaging
07 December 2010
Tyramide Signal Amplification for Imaging Applications: Techniques for the Most Challenging IHC and ISH Targets
12 October 2010
Real-time, label-free cell monitoring: Overcoming the limitations of endpoint analysis
07 July 2010
Harnessing the Power of Single Cell Analysis
28 August 2009
Live Cell Imaging: Simplifying and Demystifying New York, NY
10 December 2008
Preventing and Detecting Cell Line Cross-Contamination and Misidentification New York, NY